Arnatar Therapeutics
PrivateLast Round
Series A
Apr 8, 2024
Total Funding Raised
$118.45M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Arnatar Therapeutics is a biotechnology company that develops RNA-based therapies using its proprietary DARGER platform to silence disease drivers or restore protein function for the treatment of cardiometabolic, liver, kidney, and central nervous system diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Arnatar Therapeutics Comparables
Compare Arnatar Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sanegene Bio | 78% | |
| Orfonyx Bio | 75% | |
| Harness Therapeutics | 71% |
Arnatar Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 8, 2024 | ||||
| Seed | Sep 19, 2022 |
Key People
Founding team and executive leadership
Arnatar Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Jifeng Ventures | Series A |
| New Alliance Capital | Series A |
| Legend Star | Series A |
| Bencao Capital | Series A |
| Eight Roads Ventures | Series A |
| Transfar Group | Series A |
| Huajin Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 23, 2026
Grew 43% QoQ from 14 to 20 employees.
- Jul 28, 2026
Grew 55% QoQ, from 11 to 17 employees.
Arnatar Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Arnatar Therapeutics's valuation, stock price, and market status.
Is Arnatar Therapeutics a public or private company?
Arnatar Therapeutics is a private company.
What is the current stock price of Arnatar Therapeutics?
Arnatar Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Arnatar Therapeutics worth (valuation)?
Valuation information for Arnatar Therapeutics is not publicly available.
Can I buy Arnatar Therapeutics stock?
Arnatar Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Arnatar Therapeutics's last funding round?
Arnatar Therapeutics's most recent funding round was Series A on April 9, 2024.
Who are the main investors in Arnatar Therapeutics?
Key investors in Arnatar Therapeutics include Bencao Capital, Eight Roads Ventures.
Will Arnatar Therapeutics IPO soon?
No public IPO plans have been announced for Arnatar Therapeutics.
How can I track Arnatar Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Arnatar Therapeutics's secondary market activity and sign up for updates.